Why PTN? Palatin Technologies, Inc. Analysis, Price & AI Insights | Whystock
PTN
$19.47+0.57 (+3.02%)
Market ClosedLast close May 8
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.